ThinkSabio

$MRKR

$1.14▲ +9.6% YTD

3 SEC 13D/G filings tracked · Last updated Oct 19, 2026

Filing History
News
MRKR ▲ +9.6% - Marker Therapeutics, Inc.
CP $1.14▲ +9.6%Oct 19, 2026 · ThinkSabio Blog

$MRKR - Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer…

News
MRKR ▼ -4.3% - Marker Therapeutics, Inc.
CP $1.10▲ -4.3%Sep 28, 2026 · ThinkSabio Blog

$MRKR small vol pop talk of an NIH Grant awarded to company…

News
MRKR ▼ -0.8% - Marker Therapeutics, Inc.
CP $1.20▲ -0.8%Sep 22, 2026 · ThinkSabio Blog

$MRKR - Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies…